2m 2m 2m 2m 2m 2m 2m
PRIME MEDICINE (PRME)
NASDAQ
$3.44+$0.05 (+1.56%)
Price as of Aug 21, 2026 7:55 PM EDT- $614.9MMarket Cap
- -4.51%1-Year Change
- BiotechnologyIndustry
PRIME MEDICINE (PRME)
$3.44+$0.05 (+1.56%)
PRME | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.39 | ||
Change | +$0.15 (+4.63%) | ||
Open | $3.26 | ||
High | $3.49 | ||
Low | $3.24 | ||
Previous Close | $3.24 | ||
Volume | 3,602,652 | ||
30-Day Average Volume | 2,672,322 | ||
1-Week Change | 9.71% | ||
1-Month Change | 8.65% | ||
1-Year Change | -4.51% | ||
3-Year Change | -72.14% | ||
5-Year Change | -83.24% | ||
Fundamentals | |||
Shares Outstanding | 181.4M | ||
Total Assets | $249.0M | ||
Market Cap | $614.9M | ||
Enterprise Value | $567.4M | ||
Period: QTR TTM FY | |||
Revenue | $1.2M | ||
Net Income | -$42.1M | ||
Free Cash Flow | -$41.1M | ||
EBIT | -$42.1M | ||
EBITDA | -$40.3M | ||
Net Working Capital | $65.1M | ||
EPS | -$0.24 | ||
Enterprise Value/EBITDA | -14 | ||
Enterprise Value/Revenue | 492 | ||
P/B | 15 | ||
P/E | -14 | ||
PEG | -1 | ||
Price/Free Cash Flow | -15 | ||
Price/Operating Cash Flow | -15 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 09/10/2019 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue